Collegium Pharmaceutical, Inc. (COLL)
Last updated: 2026-10-20 20:23:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Collegium Pharmaceutical, Inc. (COLL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $23.24, with a market capitalization of $754.96M and a P/E ratio of 15.63. Over the past 52 weeks, its price has ranged from $21.43 to $50.79. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$754.96M | |
$23.54 | |
$50.79 | |
$3.23 | |
$23.01 | |
433.35K | |
790.17K | |
15.63 | |
$50.79 | |
$21.43 | |
-- | |
-- |
Collegium Pharmaceutical, Inc. (COLL) After-Hours Stock Price
Collegium Pharmaceutical, Inc. (COLL) is trading at $23.25 in after-hours trading as of 2026-10-20 19:59:56, up 1.02% ($0.23) from the regular-session close of $23.01.
After-hours trading shows how investors are pricing COLL after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Collegium Pharmaceutical, Inc. (COLL) 7-Day Stock Price Change
Over the past seven days, Collegium Pharmaceutical, Inc. (COLL) moved from $22.09 to $23.24, representing a gain of 5.22% ($1.15).
The stock traded between $21.46 and $24.83 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 715.49 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
COLL 52-Week Price Position
Position in Range: 6.2%
COLL is currently trading at $23.24, placing it 6.2% of the way from its 52-week low of $21.43 to its 52-week high of $50.79. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Collegium Pharmaceutical, Inc. (COLL)?
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Collegium Pharmaceutical, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 423 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Collegium Pharmaceutical, Inc. (COLL) Stock on MEXC
Eligible investors can buy real shares of Collegium Pharmaceutical, Inc. (COLL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Collegium Pharmaceutical, Inc. (COLL) stock price today?
2.Is COLL stock going up or down today?
3.What is COLL pre-market price?
4.What is COLL after-hours price?
5.Is COLL stock trading now?
6.Where does COLL sit relative to its 52-week high and low?
7.What sector is Collegium Pharmaceutical, Inc. in?
8.What is Collegium Pharmaceutical, Inc.'s market capitalization and where is it listed?
9.How is COLL valued in terms of P/E ratio and EPS?
10.Does Collegium Pharmaceutical, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
COLL Stock Calculator
Estimate the value between COLL shares and USD.
COLL Shares to USD
1.00 COLL shares = 23.244 USD
Calculations are estimates based on the latest available price and are for reference only.




